diabetes mellitus management. important points: in history, examination, investigations and...

39
DIABETES MELLITUS Management

Upload: hillary-carter

Post on 29-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

DIABETES MELLITUS

Management

Page 2: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

IMPORTANT POINTS:IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT

– Control: good / poor? Treatment?

– Complications

– Cardiovascular risk factors

Page 3: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

HISTORY: special points

Introduction: ethnic group and age Presenting complaint

– E.g. admitted for control of diabetes History of presenting complaint

– Polyuria, polydypsia……blood glucose values, also indicates control, screening

Complications – systemic review esp. CVS, Neuro, Eye, Renal, Skin, Drug history – What medication? Duration, Side effects? Compliance? P/H/O complications esp. CVS, wound infections

F/H/O type 2 DM, IHD, CVA, HBP

Social history: smoking, diet, exercise, financial aspects

Page 4: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

EXAMINATION: special points General examination

– skin infections, edema, waist CVS –

– BP, postural hypotension, JVP, cardiomegaly – peripheral pulses, bruits

RS– Infections - TB

Abdomen – Fatty liver, ascites with nephrotic syndrome

CNS– Ophthalmoscopy and cranial nerves– Mononeuritis– Amyotrophy– Autonomic (postural hypotension)– Peripheral neuropathy

• Muscle wasting• Early sensory signs: vibration sense, absent jerks• Romberg’s test

FEET– Skin, bact / fungal infections, gangrene, pulses, neuropathy, ulcers, osteomyelitis,

Page 5: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

INVESTIGATIONS

Assess glycemic control

Extent of complications

Risk factors for CAD

Page 6: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

INVESTIGATIONS

Assess glycemic control: blood glc levels, HbA1c, fructosamine

Extent of complications: ECG, A/B, Renal, CXR, ECHO,

Risk factors for CAD: BP, lipids, metabolic syndrome

Page 7: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

PRINCIPLES OF TREATMENT

Good glycemic control Prevent or treat complications Manage risk factors for CAD

Page 8: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

PRINCIPLES OF TREATMENTTYPE 2 DM

Good glycemic control Prevent or treat complications Manage risk factors for CAD

Page 9: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

GLYCAEMIC CONTROL

A healthy lifestyle OHD Insulin

Page 10: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

HEALTHY LIFE STYLE

Healthy eating Weight control Exercise Smoking and alcohol

Page 11: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

HEALTHY LIFE STYLE

Healthy diet Exercise Weight control: BMI <23 kg / m2

Smoking and alcohol

Page 12: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

DIET

Carbohydrates– 60% of calories– Low glycaemic foods preferred– Restrict refined sugars and high fiber– Non-nutrient sweeteners– Avoid alcohol

Fats– <30% of calories– <7% saturated– <200 g of cholesterol– Avoid trans-fatsEat fish twice a week

Page 13: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

EXERCISE

Control of blood sugar Increases insulin sensitivity (danger of hypo) Weight loss Reduces body fat and maintains muscle bulk Lowers blood pressure Cardiovascular fitness

Page 14: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

DRUGS

Decreased absorption

Decreased hepatic glc output Increased peripheral glc uptake

Stimulate insulin release

Page 15: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

OHD

Decreased absorption

Decreased hepatic glc output Increased peripheral glc uptake

Acarbose

PioglitazonMetformin

Stimulate insulin releaseSulphonyluria, Repaglinide

Page 16: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

OHD

Biguanides: metformin Sulphonyluria: glyclazide, glipizide Thiozolidinediones: pioglitazone Alpha glucosidase inhibitor: acarbose Non-sulphonyluria secretagogues: repaglinide

Page 17: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

DRUG THERAPY

Asymptomatic

Life-style modification Drugs

Page 18: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

DRUG THERAPY

Asymptomatic

Metformin

Life-style modification Drugs

Page 19: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

DRUG THERAPY

Asymptomatic SymptomaticHigh HbA1C

High FPG

High RPG

Life-style modification Drugs

Page 20: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

DRUG THERAPY

TYPE 2 D M Asymptomatic Type 2 DM ? Metformin

Symptomatic Type 2 DM HbA1c >8% FBS > 11.1 RBG > 14.0

TYPE 1 DM Insulin

Page 21: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

TYPE 2 DM

Obese T2DM: Metformin If intolerant give acarbose or TZD HbA1C >10%: combination of metformin and

gliclazide (sulphonyluria)

Non-obese T2DM: Metformin or sulphonyluria

(gliclazide)

Page 22: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

GOALS OF GLYCEMIC CONTROL

– FBS 4.4-6.1

– Non-fasting 4.4-8.0

– HbA1C <6.5%

Page 23: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

Mono-therapy

Combination of metformin + gliclazide

OR metformin + acarbose / TZDs (esp in obese)

Then add third drug

Add insulin

Page 24: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

ADD INSULIN

If not reaching target after 3 months of optimum combination therapy (metformin, gliclazide, acarbose, pioglitazone)

FBG> 7.0 mmol/L HbA1c>6.5% Maximum doses of OHD

Page 25: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

INSULIN

Rapid-acting analogues Fast-acting insulin (short-acting) Intermediate-acting insulin Long-acting insulin Very long-acting analogues

Lancet 2006;367:847

Page 26: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

INSULINS

Rapid-acting analogues: insulin lispro, Humalog (4-6 hours) Fast-acting: soluble insulin, Actrapid, Humulin R (6-10 hours) Intermediate-acting: (10-16 hours)

– isophane; NPH, Humulin N– Humulin L (Lente insulin)

Long-acting insulin: Ultralente 24 hours Very long-acting analogues: (24 hours)

– Insulin glargine (Lantus)– Insulin detemir (Levemir)

Lancet 2006;367:847

Page 27: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

INSULIN REGIMES

Premixed (Mixtard) b.d. (30% soluble + 70% isophane)

Before meals rapid or short, with bedtime intermediate or long acting analog

Bedtime Long-acting or intermediate insulin, day time sulphonyluria + metformin

Page 28: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

INSULIN REGIMES

Basal-bolus (T1DM) Insulin pumps (continuous subcutaneous)

Twice daily mixtard (Often for T2DM)– 2/3 of total dose in morning (2/3 long acting = e.g. 30:70

Mixtard)– 1/3 of total dose in evening (1/2 long acting = e.g. 50;50 Mixtard)

Lancet 2006;367:847

Page 29: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

INSULIN PUMP

Page 30: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

COMPLICATIONS OF TREATMENT

Hypoglycaemia Hypoglycaemia unawareness

Page 31: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

NEWER DRUGS IN TYPE 2 DM

Exenatide– Stimulates insulin secretion

– Glucagon-like-peptide

– Given S.C

Page 32: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

PREVENT COMPLICATIONS OF DIABETES

Page 33: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

PREVENT COMPLICATIONS OF DIABETES

Nephropathy Neuropathy Retinopathy Cardiovascular: IHD, CVA/TIA. PVD Diabetic foot

Page 34: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

PREVENT COMPLICATIONS OF DIABETES

Good glycaemic control Screen for complications Action to prevent specific complications

Page 35: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

PREVENT COMPLICATIONS OF DIABETES

Good glycaemic control Screen: regular BP, lipids, eye and renal check up Action to prevent specific complications:

– ACEI or ARBs in early renal involvement– Aspirin if IHD, or high risk of IHD (microalbuminuria, metabolic

syndrome, >35, high-risk ethnic groups, family history) – Control hypertension (macrovascular, retinopathy and

nephropathy)– Treat hyperlipidaemia (macrovascular and nephropathy)– Stop smoking (IHD, CVA, TIA, PVD)– Diabetic foot

Page 36: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

CONTROL HBP AND HYPERLIPIDAEMIA

– LDL <2.6

– TG <1.7

– HDL >1.1

– BP <130/80

– BP <120/75 (with renal impairment or gross proteinuria)

Page 37: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

COMPLICATIONS: DIABETIC FOOT

Slides current until 2008

Diabetic neuropathyFoot education

Curriculum Module I I I -7cSlide 8 of 34

Wash, touch and look at feet every day

• Do not soak feet

• Test water temperature

• Wash and dry between toes

• Avoid herbs and ointments

• Examine feet in good light

Page 38: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

COMPLICATIONS: DIABETIC FOOT

Slides current until 2008

Diabetic neuropathyFoot education

Curriculum Module I I I -7cSlide 15 of 34

How to care for toenails

• Do not to let nail grow too long

• Cut straight across

• File sharp edges

• Ask a friend or relative

Page 39: DIABETES MELLITUS Management. IMPORTANT POINTS: IN HISTORY, EXAMINATION, INVESTIGATIONS AND TREATMENT –Control: good / poor? Treatment? –Complications

COMPLICATIONS

Slides current until 2008

Diabetic neuropathyFoot education

Curriculum Module I I I -7cSlide 11 of 34

Learn to look for:

Hammer toe Clawed toes